As the private sector contributes to advancing equity, corporate leaders are looking for ways to create positive impact through new practices, policies and, importantly—their core business. They consider how their purpose, culture, and governance align with their equity ambitions and the leadership it takes to bring commitments to fruition.
Hear from a Global Fortune 500 CEO who is reimagining the ways his company uses innovative science, technology, and an “inspired, curious, unbossed” culture to deliver greater access to medicines.
On November 29, 2022, Vas Narasimhan, M.D., CEO of global medicines company Novartis, spoke with Alyson Shontell, Editor-in-Chief of Fortune, spanning the topics of strategy, innovation, impact, and leadership, with learnings and advice relevant for all business leaders looking to advance equity today.
- Vas Narasimhan, M.D. – CEO, Novartis
- Alyson Shontell – Editor-in-Chief, Fortune
- Sebastien Mazzuri, M.D. (event host) – Managing Director, FSG